Selected new reviews and commentaries, 1 October 2010

30 September 2010

Preparing for a consumer-driven genomic age. Evans JP, Dale DC, Fomous C. N Engl J Med. 2010 Sep 16;363(12):1099-103.

Risks of Presymptomatic Direct-to-Consumer Genetic Testing.
Annes JP, Giovanni MA, Murray MF. N Engl J Med. 2010 Sep 16;363(12):1100-1.

Personalized investigation.
Dolgin E. Nat Med. 2010 Sep;16(9):953-5.

Ten years of genetics and genomics: what have we achieved and where are we heading?
Heard E et al. Nat Rev Genet. 2010 Oct;11(10):723-33.

Exclusion of genetic information from the medical record: ethical and medical dilemmas.
Klitzman R. JAMA. 2010 Sep 8;304(10):1120-1.

Screening student athletes for sickle cell trait - a social and clinical experiment.
Bonham VL, Dover GJ, Brody LC. N Engl J Med. 2010 Sep 9;363(11):997-9.

Advances in understanding cancer genomes through second-generation sequencing.
Meyerson M, Gabriel S, Getz G. Nat Rev Genet. 2010 Oct;11(10):685-96.

A question of benefit. Newborn screening
Nat Genet. 2010 Oct;42(10):811.

Infectious diseases not immune to genome-wide association.
de Bakker PI, Telenti A. Nat Genet. 2010 Sep;42(9):731-2.

Copy number variation in Parkinson's disease.

Toft M, Ross OA. Genome Med. 2010 Sep 6;2(9):62.

Global noncommunicable diseases - where worlds meet.
Narayan KM, Ali MK, Koplan JP. N Engl J Med. 2010 Sep 23;363(13):1196-8

Patent fixes for Europe.
Van Pottelsberghe de la Potterie B. Nature. 2010 Sep 23;467(7314):395.

Genetics: Exposing a DUX Tale
Mahadevan MS. Science 2010 Sep 24;329(5999):1607-1608.

GWAS identifies a common breast cancer risk allele among BRCA1 carriers.
Kraft P, Haiman CA. Nat Genet. 2010 Oct;42(10):819-20.

Gene therapy: Targeting β-thalassaemia.
Persons DA. Nature. 2010 Sep 16;467(7313):277-8.

Genomics: The long and the short of it.
Shadan S. Nature 2010 Sept 30;467:539.

Translating cancer research into targeted therapeutics.
De Bono JS, Ashworth A. Nature 2010 Sept 30;467:543-549.

More from us